In last trading session, Qualigen Therapeutics Inc (NASDAQ:QLGN) saw 1.42 million shares changing hands with its beta currently measuring -0.87. Company’s recent per share price level of $0.25 trading at $0.02 or 8.41% at ring of the bell on the day assigns it a market valuation of $2.88M. That closing price of QLGN’s stock is at a discount of -404.0% from its 52-week high price of $1.26 and is indicating a premium of 44.0% from its 52-week low price of $0.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 45.39 million shares which gives us an average trading volume of 12.82 million if we extend that period to 3-months.
Qualigen Therapeutics Inc (NASDAQ:QLGN) trade information
Upright in the green during last session for gaining 8.41%, in the last five days QLGN remained trading in the red while hitting it’s week-highest on Friday, 07/19/24 when the stock touched $0.25 price level, adding 16.58% to its value on the day. Qualigen Therapeutics Inc’s shares saw a change of -54.05% in year-to-date performance and have moved -19.65% in past 5-day. Qualigen Therapeutics Inc (NASDAQ:QLGN) showed a performance of 40.16% in past 30-days. Number of shares sold short was 4.16 million shares which calculate 0.1 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 71.09% during past 5 years.
QLGN Dividends
Qualigen Therapeutics Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Qualigen Therapeutics Inc (NASDAQ:QLGN)’s Major holders
Insiders are in possession of 5.98% of company’s total shares while institution are holding 2.31 percent of that, with stock having share float percentage of 2.45%. Investors also watch the number of corporate investors in a company very closely, which is 2.31% institutions for Qualigen Therapeutics Inc that are currently holding shares of the company.
